Abstract
Purpose:for the TomoTherapy™ system, longitudinal conformation can be improved by selecting a smaller field width but at the expense of longer treatment time. Recently, the TomoEdge™ feature has been released with the possibility to move dynamically the jaws at the edges of the target volume, improving longitudinal penumbra and enabling faster treatments. Such delivery scheme requires additional modeling of treatment delivery. Using a previously validated Monte Carlo model (TomoPen), we evaluated the accuracy of the implementation of TomoEdge in the new dose engine of TomoTherapy for 15 clinical cases.Methods:TomoPen is based on PENELOPE. Particle tracking in the treatment head is performed almost instantaneously by 1) reading a particle from a phase‐space file corresponding to the largest field and 2) correcting the weight of the particle depending on the actual jaw and MLC configurations using Monte Carlo pre‐generated data. 15 clinical plans (5 head‐and‐neck, 5 lung and 5 prostate tumors) planned with TomoEdge and with the last release of the treatment planning system (VoLO™) were re‐computed with TomoPen. The resulting dose‐volume histograms were compared.Results:Good agreement was achieved overall, with deviations for the target volumes typically within 2% (D95), excepted for small lung tumors (17 cm3), where a maximum deviation of 4.4% was observed for D95. However, such deviations were not observed for quality assurance measurements in homogeneous phantoms and were therefore attributed to dose calculation in patient geometry, not the modeling of TomoEdge. Such deviations for small lung tumors are also consistent with previously reported values for static field widths.Conclusion:For the clinical cases considered in the present study, the introduction of TomoEdge did not impact significantly the accuracy of the computed dose distributions.The author is partially supported by Accuray
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.